Replies to post #196543 on Biotech Values

[maverick_1]

Non subscribers should just do a google with title to read:
Pfizer combining with Allergan (white knighted by Actavis from Valeant's hands):

[DewDiligence]

AGN confirms “friendly” merger talks with PFE—no further details available:

http://finance.yahoo.com/news/allergan-plc-confirms-discussions-regarding-133000198.html

Allergan plc today confirmed that it has been approached by Pfizer Inc. and is in preliminary friendly discussions regarding a potential business combination transaction. Allergan stated that no agreement has been reached and there can be no certainty that these discussions will lead to a transaction, or as to the terms on which a transaction, if any, might be agreed. The company will not comment on speculation regarding the terms of a potential transaction.

I would submit that AGN would be up even more today if not for the RVNC data released today (#msg-118083612), which suggests that compelling competition to Botox is closer than some investors probably thought.